5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: Summary of key research and implications for policy and practice - Clinical sciences

Journal of the International AIDS Society

Volumn 13, Issue SUPPL. 1, 2010, Pages

  Mascolinli, Mark ^a   Kort, Rodney ^b  

^a Kort Consulting ^*

^b Kort Consulting   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INTEGRASE INHIBITOR; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; RALTEGRAVIR; SGSK 1349572; UNCLASSIFIED DRUG; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CHRONIC DISEASE; CLINICAL PRACTICE; DEATH; DEVELOPED COUNTRY; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFLAMMATORY DISEASE; INTERNATIONAL COOPERATION; MEDICAL SOCIETY; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVIEW; VERTICAL TRANSMISSION; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; DISEASE TRANSMISSION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; MEDICAL RESEARCH; PHYSIOLOGY; VIROLOGY; AFRICA SOUTH OF THE SAHARA; CLINICAL TRIAL; IMMUNOLOGY; MALARIA; TUBERCULOSIS; BASIC RESEARCH; CLINICAL RESEARCH; DISEASE COURSE; ERADICATION THERAPY; GENETIC SUSCEPTIBILITY; IMMUNOSTIMULATION; INFECTION SENSITIVITY; VIREMIA;

BIOMEDICAL RESEARCH; HIV; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; CLINICAL TRIALS AS TOPIC; MALARIA; TUBERCULOSIS;

EID: 78349233954     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-13-S1-S3     Document Type: Review

References (18)

1. Track B rapporteur report. P Tebas, 5th IAS Conference on HIV Pathogenesis Treatment and Prevention 2009 WESS102
2. Widespread ART is associated with decline in TB prevalence. K Middelkoop, R Wood, L Myer, A Whitelaw, G Kaplan, J McIntyre, LG Bekker, 5th IAS Conference on HIV Pathogenesis Treatment and Prevention WELBB105
3. The use of efavirenz is associated with a decreased incidence of tuberculosis after antiretroviral therapy initiation in an urban HIV clinic in sub-Saharan Africa. SM Hermans, A Kiragga, P Schaefer, A Kambugu, IM Hoepelman, YC Manabe, 5th IAS Conference on HIV Pathogenesis Treatment and Prevention TUPEB136
4. Epidemiology of malaria in HIV infected Ugandan patients on antiretroviral therapy (ART) - a prospective cohort study. R Kasirye, J Levin, P Munderi, L Okell, S Walker, A Mugisha, H Grosskurth, 5th IAS Conference on HIV Pathogenesis Treatment and Prevention TUPDB104
5. A randomized trial comparing highly active antiretroviral therapy regimens for virologic efficacy and the prevention of mother-to-child HIV transmission among breastfeeding women in Botswana (The Mma Bana Study). R Shapiro, M Hughes, A Ogwu, C Wester, W Snowden, M Martinez-Tristani, L Mazhani, M Essex, 5th IAS Conference on HIV Pathogenesis Treatment and Prevention WELBB101
6. Both maternal HAART and daily infant nevirapine (NVP) are effective in reducing HIV-1 transmission during breastfeeding in a randomized trial in Malawi: 28 week results of the Breastfeeding, Antiretroviral and Nutrition (BAN) Study. C Chasela, M Hudgens, D Jamieson, F Martinson, P Kazembe, I Mofolo, D Long, A Soko, SB Smith, C van der Horst, 5th IAS Conference on HIV Pathogenesis Treatment and Prevention WELBC103
7. Triple-antiretroviral (ARV) prophylaxis during pregnancy and breastfeeding compared to short-ARV prophylaxis to prevent mother-to-child transmission of HIV-1 (MTCT): the Kesho Bora randomized controlled clinical trial in five sites in Burkina Faso, Kenya. I De Vincenzi, Kesho Bora Study Group, 5th IAS Conference on HIV Pathogenesis Treatment and Prevention LBPEC01
8. Randomized clinical trial of switching to nevirapine-based therapy for infected children exposed to nevirapine prophylaxis. A Coovadia, E Abrams, R Strehlau, L Martens, G Sherman, T Meyers, L Kuhn, NEVEREST Study Team, 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention MOAB103
9. Virologic failure and second-line antiretroviral therapy (ART) in children in South Africa: the international epidemiologic databases to evaluate AIDS (IeDEA) Southern Africa collaboration. MA Davies, R Wood, G Van Cutsem, J Giddy, B Eley, H Rabie, H Moultrie, K Technau, A Boulle, 5th IAS Conference on HIV Pathogenesis Treatment and Prevention MOAB104
10. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. LH Kuller, R Tracy, W Belloso, S De Wit, F Drummond, HC Lane, B Ledergerber, J Lundgren, J Neuhaus, D Nixon, NI Paton, JD Neaton, INSIGHT SMART Study Group, PLoS Med 2008 5 e203 10.1371/journal.pmed.0050203 18942885
11. Pre-ART plasma levels of inflammation and coagulation markers are strong predictors of death after commencing ART in a South African cohort with advanced HIV disease. L Lebwaba, P Maja, 5th IAS Conference on HIV Pathogenesis Treatment and Prevention MOPEB005
12. Potent antiviral activity of S/GSK1349572, a next generation integrase inhibitor (INI), in INI-nave HIV-1-infected patients. J Lalezari, L Sloan, E DeJesus, T Hawkins, L Mccurdy, I Song, J Borland, R Stroder, R Chen, Y Lou, M Underwood, T Fujiwara, S Piscitelli, S Min, ING111521 Investigators, 5th IAS Conference on HIV Pathogenesis Treatment and Prevention TUAB105
13. S/GSK1349572 is a potent next generation HIV integrase inhibitor. A Sato, M T Kobayashi, T Yoshinaga, T Fujiwara, M Underwood, B Johns, S Foster, R Hazen, R Ferris, K Brown, E Garvey, 5th IAS Conference on HIV Pathogenesis Treatment and Prevention WEPEA097
14. S/GSK1349572: a next generation integrase inhibitor with activity against integrase inhibitor resistant clinical isolates from patients experiencing virologic failure while on raltegravir therapy. M Underwood, B Johns, A Sato, T Fujiwara, W Spreen, 5th IAS Conference on HIV Pathogenesis Treatment and Prevention WEPEA098
15. Incidence of tuberculosis during highly active antiretroviral therapy in high-income and low-income countries. SD Lawn, R Wood, Clin Infect Dis 2005 41 1783 6 10.1086/498308 16288404 (Pubitemid 41759865)
16. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. JG Kublin, P Patnaik, CS Jere, WC Miller, IF Hoffman, N Chimbiya, R Pendame, TE Taylor, ME Molyneux, Lancet 2005 365 233 40 15652606 (Pubitemid 40138017)
17. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. N French, J Nakiyingi, E Lugada, C Watera, JA Whitworth, CF Gilks, AIDS 2001 15 899 906 10.1097/00002030-200105040-00010 11399962 (Pubitemid 32424393)
18. Inflammation and HIV: a new paradigm. W El-Sadr, 5th IAS Conference on HIV Pathogenesis Treatment and Prevention MOPL104